Home /
DRC tests unprecedented antiviral against Bundibugyo Ebola variant A clinical trial begins in the Democratic Republic of Congo to evaluate an antiviral against the Bundibugyo Ebola variant.
Published 7sem · 3 sources ✓ Confirmed Major · updated 6sem
The fact The epidemic is spreading to new areas, with no recognized treatment for this variant yet.
The WHO supports the initiative, given the concerning spread.
🔗 3 sources — click a link to read an article on the topic:
Why it matters L’épidémie d’Ebola en RDC, déjà critique, pourrait trouver une réponse thérapeutique avec cet essai, crucial pour contenir un variant sans traitement validé.
What if you saw the whole news differently? Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page. → Genève World map → Auto-synthesis from 3 media sources · identified on July 14, 2026